Drugs / Efavaleukin alfa
Efavaleukin alfa
Trials 9
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 14 trials | ||||||
| Phase 1 | NCT04987333 | Aug 2021 → Oct 2022 | inflammatory disease | Amgen | Completed | No outcome recorded |
| Phase 1 | NCT05885451 | Jan → Apr 2019 | chronic graft versus host disease | Amgen | Completed | No outcome recorded |
| Phase 1 | NCT03451422 | Apr 2018 → Oct 2021 | systemic lupus erythematosus | Amgen | Completed | No outcome recorded |
| Phase 1 | NCT05873907 | Oct 2015 → Jun 2017 | chronic graft versus host disease | Amgen | Completed | No outcome recorded |
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT03410056 | May 2018 → Dec 2019 | rheumatoid arthritis | Amgen | Terminated | No outcome recorded Stop: Business |
| Phase 1/2 | NCT03422627 | Apr 2018 → Oct 2022 | chronic graft versus host disease | Amgen | Terminated | No outcome recorded Stop: Business |
| Phase 23 trials · 2 missed | ||||||
| Phase 2 | NCT05672199 | Apr 2023 → Oct 2024 | ulcerative colitis | Amgen | Terminated | No outcome recorded |
| Phase 2 | NCT04987307 | Jan 2022 → Oct 2024 | ulcerative colitis | Amgen | Terminated | Missed primary |
| Phase 2 | NCT04680637 | May 2021 → May 2023 | systemic lupus erythematosus | Amgen | Terminated | Missed primary |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 10 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Efavaleukin alfa | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04987333 ↗ |
| Known as | AMG 592 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05885451 ↗ |
| Known as | Efavaleukina alfa | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298204 ↗ |
| Known as | Efavaleukine alfa | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298204 ↗ |
| Modality | Protein / enzyme biologic | — CHEMBL4298204 ↗ |
| Route | Subcutaneous | “Efavaleukin alfa administered as a subcutaneous injection.” NCT03410056 ↗ |